Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionEllevest, Inc.
Latest Disclosed Ownership1,442 shares
Latest Disclosed Value $ 643,911
Ellevest, Inc. reports 63.68% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 11, 2026 - Ellevest, Inc. filed a 13F-HR form disclosing ownership of 1,442 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $643,911 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 881 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 63.68% during the quarter. The current value of the position is $617,666 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,442 561 63.68 644 61.15 0.0895
2026-02-10 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 881 -18 -2.00 399 13.35 0.0552
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 899 22 2.51 352 -9.74 0.0503
2025-08-05 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 877 -231 -20.85 390 -27.37 0.0623
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,108 -546 -33.01 537 -19.37 0.0358
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,654 -107 -6.08 666 -18.68 0.0384
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,761 14 0.80 819 0.12 0.0454
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,747 65 3.86 819 16.36 0.0491
2024-05-13 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,682 -7 -0.41 703 2.33 0.0436
2024-02-06 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,689 -121 -6.69 687 9.22 0.0468
2023-11-09 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,810 232 14.70 629 13.33 0.0484
2023-08-09 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,578 117 8.01 555 20.65 0.0418
2023-05-04 2023-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,461 265 22.16 460 33.33 0.0358
2023-02-03 2022-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,196 103 9.42 345 9.18 0.0291
2022-11-02 2022-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,093 235 27.39 316 30.58 0.0299
2022-07-18 2022-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 858 645 302.82 242 332.14 0.0227
2022-04-19 2022-03-31 13F VERTEX PHARMACEUTICALS Stock 92532F100 213 -41 -16.14 56 0.00 0.0047
2022-01-24 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 254 -1,132 -81.67 56 -77.69 0.0050
2021-10-19 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,386 -71 -4.87 251 -14.63 0.0244
2021-07-13 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,457 271 22.85 294 15.29 0.0292
2021-05-03 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,186 215 22.14 255 11.35 0.0308
2021-02-04 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 971 171 21.38 229 5.05 0.0335
2020-10-26 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 800 161 25.20 218 17.20 0.0391
2020-07-06 2020-06-30 13F VERTEX PHARMACEUTICALS Stock 92532F100 639 307 92.47 186 135.44 0.0398
2020-04-13 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 332 111 50.23 79 64.58 0.0219
2020-02-05 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 221 200 952.38 48 1,100.00 0.0133
2019-10-08 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 21 -10 -32.26 4 -33.33 0.0014
2019-08-20 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 31 11 55.00 6 50.00 0.0024
2019-05-01 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 20 0 0.00 4 33.33 0.0019
2019-01-25 2018-12-31 13F VERTEX PHARMACEUTICALS INC COM Common Stock 92532F100 20 20 3 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.